E3泛素连接酶RNF5通过泛素化降解HRD1改善NASH
本研究探讨内质网定位E3泛素连接酶RNF5在NASH中的作用及机制。多物种肝脏中RNF5表达显著降低;肝细胞过表达Rnf5减轻PAOA诱导的脂质蓄积和炎症,而敲低则加重。肝细胞特异性Rnf5敲除加重饮食诱导NASH小鼠的脂肪变性、炎症和纤维化。机制上RNF5直接结合HRD1并促进其K48/K33连接泛素化及蛋白酶体降解,提示RNF5-HRD1轴可能成为NASH防治靶点。
要点
- RNF5在NASH肝脏中表达显著降低,过表达可减轻肝细胞脂质蓄积和炎症。
- 肝细胞特异性Rnf5敲除加重饮食诱导NASH小鼠的脂肪变性、炎症和纤维化。
- RNF5直接结合HRD1并促进其K48/K33泛素化及蛋白酶体降解。
核心结论
- RNF5通过靶向HRD1经泛素介导的蛋白酶体途径抑制NASH进展。
研究设计与样本
- 基础实验研究:检测多物种NASH肝脏RNF5表达,在原代小鼠肝细胞中过表达或敲低Rnf5,并使用肝细胞特异性Rnf5敲除小鼠接受饮食诱导NASH。
主要发现
- RNF5在包括人在内的多物种NASH肝脏中表达显著降低。
- Rnf5过表达显著减轻PAOA诱导的肝细胞脂质蓄积和炎症,基因沉默则加重。
- 肝细胞特异性Rnf5敲除显著加重饮食诱导NASH小鼠的肝脏脂肪变性、炎症反应和纤维化。
- RNF5直接结合HRD1并促进其K48链接和K33链接泛素化及后续蛋白酶体降解。
- Hrd1过表达显著加重PAOA诱导的脂质蓄积和炎症,shRNA敲低Hrd1则起相反作用;Hrd1敲低显著减轻Rnf5缺失肝细胞中PAOA诱导的脂质沉积及相关基因上调。
关键数值与推荐
- 原代小鼠肝细胞中PAOA诱导脂质蓄积和炎症,Rnf5过表达减轻、沉默加重。
- 肝细胞特异性Rnf5敲除小鼠接受饮食诱导NASH,肝脏脂肪变性、炎症和纤维化显著加重。
- RNF5促进HRD1的K48链接和K33链接泛素化及蛋白酶体降解。
- Hrd1敲低显著减轻Rnf5缺失肝细胞中PAOA诱导的脂质沉积及相关基因上调。
临床怎么用
- 靶向RNF5-HRD1轴可能为NASH发病机制提供认识,并为NASH预防和治疗策略开发提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: NAFLD is the most prevalent chronic liver disease worldwide, but no effective pharmacological therapeutics are available for clinical use. NASH is the more severe stage of NAFLD. During this progress, dysregulation of endoplasmic reticulum (ER)-related pathways and proteins is one of the predominant hallmarks. We aimed to reveal the role of ring finger protein 5 (RNF5), an ER-localized E3 ubiquitin-protein ligase, in NASH and to explore its underlying mechanism. APPROACH AND RESULTS: We first inspected the expression level of RNF5 and found that it was markedly decreased in livers with NASH in multiple species including humans. We then introduced adenoviruses for Rnf5 overexpression or knockdown into primary mouse hepatocytes and found that palmitic acid/oleic acid (PAOA)-induced lipid accumulation and inflammation in hepatocytes were markedly attenuated by Rnf5 overexpression but exacerbated by Rnf5 gene silencing. Hepatocyte-specific Rnf5 knockout significantly exacerbated hepatic steatosis, inflammatory response, and fibrosis in mice challenged with diet-induced NASH. Mechanistically, we identified 3-hydroxy-3-methylglutaryl CoA reductase degradation protein 1 (HRD1) as a binding partner of RNF5 by systematic interactomics analysis. RNF5 directly bound to HRD1 and promoted its lysine 48 (K48)-linked and K33-linked ubiquitination and subsequent proteasomal degradation. Furthermore, Hrd1 overexpression significantly exacerbated PAOA-induced lipid accumulation and inflammation, and short hairpin RNA-mediated Hrd1 knockdown exerted the opposite effects. Notably, Hrd1 knockdown significantly diminished PAOA-induced lipid deposition, and up-regulation of related genes resulted from Rnf5 ablation in hepatocytes. CONCLUSIONS: These data indicate that RNF5 inhibits NASH progression by targeting HRD1 in the ubiquitin-mediated proteasomal pathway. Targeting the RNF5-HRD1 axis may provide insights into the pathogenesis of NASH and pave the way for developing strategies for NASH prevention and treatment.
引用
- Yang Q, Chen X, Zhang Y, et al. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1. Hepatology. 2021. PMID: 34272738. doi:10.1002/hep.32061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。